The global cellular pathology market was valued at US$ 32.7 Billion in 2022 and is expected to reach US$ 78.3 Billion by 2033. The services with around 48.0% value share, has topped the global market within the product and services category in 2022 and is expected to grow at a CAGR of close to 7.5% over the forecast period (2023 to 2033)
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 32.7 Billion |
| Market Value 2023 | US$ 35.2 Billion |
| Market Value 2033 | US$ 78.3 Billion |
| CAGR 2023 to 2033 | 8.3% |
| Market Share of Top 5 Countries | 57.4% |
| Key Market Players | Leica Biosystems, Nussloch GmbH (Danaher Corporation), BioGenex. Hologic, Inc., Epredia, Sakura Finetek, F. Hoffmann-La Roche Ltd., Merck KGaA, Gestalt Diagnostics, Carl Zeiss AG, Olympus Corporation, Abbott Laboratories, Inc., and NeoGenomics Laboratories. |
Cellular pathology is a branch of medicine that studies organs and tissues, diagnosing illnesses and medical problems. It enables high-resolution anatomic assessment of phenotypes, enabling histology to discern diagnostic and characteristic cellular changes in diseased tissues. This interpretative power is evident in every major human disease, relying on unbiased pan-cellular staining.
The COVID-19 pandemic led to the replacement of traditional cellular pathology reporting with personal microscopes and connected monitors. Oncology workflows use complex biomarkers, requiring tumor tissue for decision-making, requiring time and resources. AI's potential in computer vision applications has led to opportunities in digital pathology, but challenges remain.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for cellular pathology was around 9.8% of the overall US$ 9.56 Billion of the global pathology laboratories market in 2022.
The COVID-19 pandemic had a huge influence on health care, resulting in a move away from multiheaded microscopes and toward personal microscopes and linked monitors for histopathology reporting. Technological advances and new information have had a tremendous influence on how medicine and health care are practiced and delivered. These developments have had an influence on clinical services such as radiography and pathology, necessitating new trends and problems in service delivery.
The increase in prevalence of chronic disorders has led to rise in demand for diagnostic services, including cytopathology. As the number of individuals with chronic disease continue to grow, there is greater need for accurate and timely diagnoses to guide appropriate treatment plans.
The increased prevalence has resulted in higher demand for pathology lab services, including histology. Pathology labs play a crucial role in diagnosing and monitoring chronic diseases, as they provide valuable insights into the cellular and molecular changes occurring in the body. Cellular pathology helps identify tissue abnormalities at cellular level, aiding in accurate diagnosis and staging of diseases. Owed to the above factors, the global market is projected to grow at CAGR of 8.3% in forecasted period.
Pathology practice has seen a rise in demand for diagnostic pathology services, as well as improvements in turnaround time and adherence to laboratory accreditation and quality assurance regulatory agencies. These improvements have also been aided by sub-specialization, interdisciplinary team meetings, and advances in information technology and digital imaging.
Patients and healthcare professionals are becoming increasingly aware of the value of early and precise diagnosis. Patients are taking more active role in taking control of their health and seeking prompt medical attention. The importance of cellular pathology in making accurate diagnoses and directing treatment choices is also becoming recognized by healthcare practitioners.
Growing market consolidation actions have been observed in the cellular pathology sector, with bigger pathology service providers purchasing smaller, specialized laboratories. The combination of cutting-edge technology and knowledge made possible by this consolidation has also made cellular pathology testing more precise and effective.
Cellular pathology market growth has been attributed to a number of factors, including an increase in the prevalence of chronic diseases, a preference for path lab services, growing public awareness of the value of cellular pathology, and market consolidation activities. This trend is expected to continue as long as there is a demand for accurate and timely diagnostic services.
Principal Consultant
As a result of growing demand, adherence to cancer case reporting rules, better turnaround time, laboratory accreditation, and quality assurance requirements, clinical pathology services are confronting problems. Sub-specialization, interdisciplinary team meetings, a drop in autopsies, fast breakthroughs in procedures, and advances in information technology and digital imaging are putting pressure on cellular pathology. Pathology services must adapt to new trends, a rising number of biopsies, and emerging procedures in order to satisfy these needs.
For proper diagnosis and testing, the cellular pathology industry relies on innovative technologies and equipment. However, these technologies frequently come at a cost. Acquiring and maintaining modern instruments, such as digital imaging systems and automated slide scanners, may be expensive. Smaller pathology labs and healthcare organizations with limited finances have a problem in investing in these technologies. The high cost may also result in higher service charges for patients, limiting access to cellular pathology services.
Strict regulatory criteria maintain patient safety and diagnostic accuracy in the cellular pathology sector. Guidelines and standards for laboratory techniques, quality control, and proficiency testing are imposed by regulatory organizations. Compliance with these regulations can be complicated and time-consuming, necessitating the use of specialized resources and experience. Small laboratories with minimal resources may struggle to meet regulatory standards. These constraints underscore the difficulties that the cellular pathology market is facing.
The USA occupies 91.1% value share in North America in 2022. Chronic illnesses can cause mortality, hospitalization, and impaired quality of life, making them the greatest cause of death and disability in the United States. Cellular pathology plays important role in diagnosis of these illnesses, this makes USA prominent market for cellular pathology in North America.
India expenditure on cellular pathology in 2022 was US$ 2.3 Billion.
The risk increases proportionally to the intensity and duration of exposure to each carcinogen. The prevalence of cancer is associated with poor hygiene, diet, or viral infections.
Individual susceptibilities to these risk factors vary within the general population, and site-specific data from different parts of the country provide clues to the etiological factors responsible for this significant variation. Diagnosis of the disease is required; cellular pathology laboratories fill the gap and aid in prompt detection. As a result, India is a lucrative market for the cellular pathology industry.
In 2022, the Germany held a dominant global revenue in the Europe market and contributed around US$ 1.9 Billion.
By using augmented reality microscopy, areas suspicious of tumors are marked in the pathologist's field of view using a light pointer. Similar approaches are being pursued in clinical decision support systems. AI-assisted approaches are being evaluated in Germany, with products designed for routine diagnostics in radiology and pathology. As a result of technological advancements, Germany has become a significant market for cellular pathology.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By product and services, services section covered 48.0% market shares in world in 2022. Pathology services in high-income countries involve various disciplines and sub-specialties, divided into clinical pathology and anatomic pathology. These services are provided through central laboratories, smaller laboratories in rural environments, and small laboratories in conjunction with university departments.
Central laboratories provide infrastructure, specimen collection services, transport, reception, and electronic patient records, while smaller laboratories offer limited tests and point-of-care testing. These laboratories also undertake research and provide education and training in pathology and related disciplines. Thus cellular pathology diagnosis services are predicted to expand rapidly between 2023 and 2033.
The market value of disease diagnosis in cellular pathology is US$ 16.2 Billion, representing for a sizable 49.5% market share in 2022.
Pathology is critical in disease monitoring, detecting new illnesses, maintaining disease registries, and assisting with clinical care. It aids in determining illness severity and prognosis, as well as dictating treatment options for patients and evaluating clinical response. However, when non-communicable illnesses grow more common, the rate of misdiagnosis may increase, resulting in wasted deaths, protracted suffering, and societal disturbance. A lack of data for illness surveillance and registries impedes public policy and resource allocation. Hence disease diagnosis in cellular pathology is preferred prominently.
The hospitals have a considerable presence in the cellular pathology market, accounting for 46.9% of end users in 2022, and exhibiting a high CAGR of 7.5% over the forecast period.
In high-income nations, hospital pathology services are often supplied by central laboratories with shared equipment and computerized patient data.
Collaborations and partnership among healthcare providers, research institutions, and technology businesses can encourage innovation and hasten cellular pathology. Collaboration in research, development, and commercialization leads to market expansion and the creation of new applications. Numerous large firms compete in the field of cellular pathology. Among the well-known players in this field are:
Similarly, recent developments related to the company’s providing the cellular pathology services have been tracked by the team at Future Market Insights, which are available in the full report.
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2016 to 2022 |
| Market Analysis | US$ Million for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, Nordics, China, Japan, South Korea, India, Indonesia, Thailand, Philippines, Malaysia, Vietnam Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa. |
| Key Market Segments Covered | Product & Services, Application, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The market acquired US$ 32.7 billion in 2022.
Pathology services in high-income countries are likely to expand significantly.
India is estimated to hold a 6.9% market share in 2022.
Germany accounted for a market share of 5.9% in 2022.
The global market expanded at a CAGR of 6.6% between 2018 and 2022.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Products & Services Adoption/Usage Analysis
4.2. Products USP/ Features Analysis
4.3. Cancer Statistics, By Key Countries
4.4. Disease Epidemiology
4.5. Clinical Applications of AI (Artificial Intelligence) in Pathology
4.6. Regulatory Landscape
4.6.1. Regulatory Frameworks in USA.
4.6.2. Regulatory Frameworks in Europe
4.6.3. Regulatory Frameworks in India
4.6.4. Regulatory Frameworks in Australia
4.7. Porter’s Analysis
4.8. PESTLE Analysis
4.9. Value Chain Analysis
4.10. Unmet Needs
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure
5.1.2. Global Life Expectancy Market Outlook
5.1.3. R&D funding by Region
5.1.4. R&D funding by Country
5.1.5. Global Pathology Laboratories Market Overview – Parent Market Analysis
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Increased Prevalence of Chronic Diseases
5.2.3. Technological Advancements in Molecular Diagnostics
5.2.4. New Product Launches
5.2.5. Increasing Focus on Personalized Medicine
5.2.6. Strategic Collaborations and Partnerships
5.2.7. Cost of Product
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Volume) Analysis 2016 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Volume (Units) Analysis, 2016 to 2022
6.2. Current and Future Market Volume (Units) Analysis and Forecast Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market – Pricing Assessment
7.1. Regional Pricing Analysis
7.2. Pricing Break-up
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2016 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2016 to 2022
8.2. Current and Future Market Size (US$ Million) Analysis and Forecast Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
9. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, By Products & Services
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product & Services, 2016 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product & Services, 2023 to 2033
9.3.1. Instruments
9.3.1.1. Microtomes & Cryostat
9.3.1.2. Pathology Workstations
9.3.1.3. Slide Strainers
9.3.1.4. Tissue Processers
9.3.1.5. Other Instruments
9.3.2. Consumables
9.3.2.1. Fixation Solutions and Stains
9.3.2.2. Glass Slides & Cover Slips
9.3.2.3. Sample Chambers
9.3.2.4. Cassettes
9.3.2.5. Reagents & Antibodies
9.3.2.6. Probes & Kits
9.3.2.7. Other Consumables
9.3.3. Services
9.3.3.1. Cytopathology
9.3.3.2. Histopathology
9.4. Market Attractiveness Analysis By Product & Services
10. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Application, 2016 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
10.3.1. Disease Diagnosis
10.3.2. Drug Discovery and Development
10.3.3. Therapeutic Research
10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By End User, 2016 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
11.3.1. Hospitals
11.3.2. Diagnostic Laboratories
11.3.3. Academic Research Institutes
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, by Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2016 to 2022
12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis Forecast By Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East and Africa
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2016 to 2022 and Forecast 2023 to 2033
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2016 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. USA.
13.3.1.2. Canada
13.3.2. By Product & Services
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis By Region
13.4.1. By Country
13.4.2. By Product & Services
13.4.3. By Application
13.4.4. By End User
13.5. Market trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. USA. Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product & Services
13.8.1.2.2. By Application
13.8.1.2.3. By End User
13.8.2. Canada Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product & Services
13.8.2.2.2. By Application
13.8.2.2.3. By End User
14. Latin America Market Analysis 2016 to 2022 and Forecast 2023 to 2033
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2016 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product & Services
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis By Region
14.4.1. By Country
14.4.2. By Product & Services
14.4.3. By Application
14.4.4. By End User
14.5. Market trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Brazil Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product & Services
14.8.1.2.2. By Application
14.8.1.2.3. By End User
14.8.2. Mexico Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product & Services
14.8.2.2.2. By Application
14.8.2.2.3. By End User
14.8.3. Argentina Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product & Services
14.8.3.2.2. By Application
14.8.3.2.3. By End User
15. Europe Market Analysis 2016 to 2022 and Forecast 2023 to 2033
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Million) Volume (Units) Analysis, By Market Taxonomy, 2016 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. United Kingdom.
15.3.1.2. Germany
15.3.1.3. Italy
15.3.1.4. France
15.3.1.5. Spain
15.3.1.6. Russia
15.3.1.7. Nordic Countries
15.3.1.8. BENELUX
15.3.1.9. Rest of Europe
15.3.2. By Product & Services
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis By Region
15.4.1. By Country
15.4.2. By Product & Services
15.4.3. By Application
15.4.4. By End User
15.5. Market trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. United Kingdom. Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product & Services
15.8.1.2.2. By Application
15.8.1.2.3. By End User
15.8.2. Germany Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product & Services
15.8.2.2.2. By Application
15.8.2.2.3. By End User
15.8.3. Italy Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product & Services
15.8.3.2.2. By Application
15.8.3.2.3. By End User
15.8.4. France Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product & Services
15.8.4.2.2. By Application
15.8.4.2.3. By End User
15.8.5. Spain Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Product & Services
15.8.5.2.2. By Application
15.8.5.2.3. By End User
15.8.6. Russia Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Product & Services
15.8.6.2.2. By Application
15.8.6.2.3. By End User
15.8.7. Nordic Countries Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Product & Services
15.8.7.2.2. By Application
15.8.7.2.3. By End User
15.8.8. BENELUX Market Analysis
15.8.8.1. Introduction
15.8.8.2. Market Analysis and Forecast by Market Taxonomy
15.8.8.2.1. By Product & Services
15.8.8.2.2. By Application
15.8.8.2.3. By End User
16. South Asia Market Analysis 2016 to 2022 and Forecast 2023 to 2033
16.1. Introduction / Key Findings
16.2. Historical Market Size (US$ Million) Volume (Units) Analysis, By Market Taxonomy, 2016 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Thailand
16.3.1.4. Philippines
16.3.1.5. Malaysia
16.3.1.6. Vietnam
16.3.1.7. Rest of South Asia
16.3.2. By Product & Services
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis By Region
16.4.1. By Country
16.4.2. By Product & Services
16.4.3. By Application
16.4.4. By End User
16.5. Market trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product & Services
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. Indonesia Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product & Services
16.8.2.2.2. By Application
16.8.2.2.3. By End User
16.8.3. Thailand Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product & Services
16.8.3.2.2. By Application
16.8.3.2.3. By End User
16.8.4. Philippines Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product & Services
16.8.4.2.2. By Application
16.8.4.2.3. By End User
16.8.5. Malaysia Market Analysis
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Product & Services
16.8.5.2.2. By Application
16.8.5.2.3. By End User
16.8.6. Vietnam Market Analysis
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Product & Services
16.8.6.2.2. By Application
16.8.6.2.3. By End User
17. East Asia Market Analysis 2016 to 2022 and Forecast 2023 to 2033
17.1. Introduction / Key Findings
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2016 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product & Services
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis By Region
17.4.1. By Country
17.4.2. By Product & Services
17.4.3. By Application
17.4.4. By End User
17.5. Market trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. China Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product & Services
17.8.1.2.2. By Application
17.8.1.2.3. By End User
17.8.2. Japan Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product & Services
17.8.2.2.2. By Application
17.8.2.2.3. By End User
17.8.3. South Korea Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product & Services
17.8.3.2.2. By Application
17.8.3.2.3. By End User
18. Oceania Market Analysis 2016 to 2022 and Forecast 2023 to 2033
18.1. Introduction / Key Findings
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2016 to 2022
18.3. Current and Future Market Size (US$ Million) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product & Services
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis By Region
18.4.1. By Country
18.4.2. By Product & Services
18.4.3. By End User
18.5. Market trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. Australia Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product & Services
18.8.1.2.2. By Application
18.8.1.2.3. By End User
18.8.2. New Zealand Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product & Services
18.8.2.2.2. By Application
18.8.2.2.3. By End User
19. Middle East and Africa Market Analysis 2016 to 2022 and Forecast 2023 to 2033
19.1. Introduction / Key Findings
19.2. Historical Market Size (US$ Million) Volume (Units) Analysis, By Market Taxonomy, 2016 to 2022
19.3. Current and Future Market Size (US$ Million) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. South Africa
19.3.1.4. Northern Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product & Services
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis By Region
19.4.1. By Country
19.4.2. By Product & Services
19.4.3. By Application
19.4.4. By End User
19.5. Market trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. GCC Countries Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product & Services
19.8.1.2.2. By Application
19.8.1.2.3. By End User
19.8.2. Türkiye Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product & Services
19.8.2.2.2. By Application
19.8.2.2.3. By End User
19.8.3. South Africa Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product & Services
19.8.3.2.2. By Application
19.8.3.2.3. By End User
19.8.4. Northern Africa Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Product & Services
19.8.4.2.2. By Application
19.8.4.2.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players (%)
20.3. Market Concentration
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive
21.2.1. Leica Biosystems Nussloch GmbH (Danaher Corporation)
21.2.1.1. Overview
21.2.1.2. Product & Services Portfolio
21.2.1.3. Key Financials
21.2.1.4. Sales Footprint
21.2.1.5. SWOT Analysis
21.2.1.6. Strategy Overview
21.2.1.6.1. Marketing Strategies
21.2.1.6.2. Product & Services Strategies
21.2.1.6.3. Channel Strategies
21.2.2. BioGenex
21.2.2.1. Overview
21.2.2.2. Product & Services Portfolio
21.2.2.3. Key Financials
21.2.2.4. Sales Footprint
21.2.2.5. SWOT Analysis
21.2.2.6. Strategy Overview
21.2.2.6.1. Marketing Strategies
21.2.2.6.2. Product & Services Strategies
21.2.2.6.3. Channel Strategies
21.2.3. Sanofi S.A.
21.2.3.1. Overview
21.2.3.2. Product & Services Portfolio
21.2.3.3. Key Financials
21.2.3.4. Sales Footprint
21.2.3.5. SWOT Analysis
21.2.3.6. Strategy Overview
21.2.3.6.1. Marketing Strategies
21.2.3.6.2. Product & Services Strategies
21.2.3.6.3. Channel Strategies
21.2.4. Hologic, Inc.
21.2.4.1. Overview
21.2.4.2. Product & Services Portfolio
21.2.4.3. Key Financials
21.2.4.4. Sales Footprint
21.2.4.5. SWOT Analysis
21.2.4.6. Strategy Overview
21.2.4.6.1. Marketing Strategies
21.2.4.6.2. Product & Services Strategies
21.2.4.6.3. Channel Strategies
21.2.5. Epredia
21.2.5.1. Overview
21.2.5.2. Product & Services Portfolio
21.2.5.3. Key Financials
21.2.5.4. Sales Footprint
21.2.5.5. SWOT Analysis
21.2.5.6. Strategy Overview
21.2.5.6.1. Marketing Strategies
21.2.5.6.2. Product & Services Strategies
21.2.5.6.3. Channel Strategies
21.2.6. Sakura Finetek
21.2.6.1. Overview
21.2.6.2. Product & Services Portfolio
21.2.6.3. Key Financials
21.2.6.4. Sales Footprint
21.2.6.5. SWOT Analysis
21.2.6.6. Strategy Overview
21.2.6.6.1. Marketing Strategies
21.2.6.6.2. Product & Services Strategies
21.2.6.6.3. Channel Strategies
21.2.7. F. Hoffmann-La Roche Ltd.
21.2.7.1. Overview
21.2.7.2. Product & Services Portfolio
21.2.7.3. Key Financials
21.2.7.4. Sales Footprint
21.2.7.5. SWOT Analysis
21.2.7.6. Strategy Overview
21.2.7.6.1. Marketing Strategies
21.2.7.6.2. Product & Services Strategies
21.2.7.6.3. Channel Strategies
21.2.8. Merck KGaA
21.2.8.1. Overview
21.2.8.2. Product & Services Portfolio
21.2.8.3. Key Financials
21.2.8.4. Sales Footprint
21.2.8.5. SWOT Analysis
21.2.8.6. Strategy Overview
21.2.8.6.1. Marketing Strategies
21.2.8.6.2. Product & Services Strategies
21.2.8.6.3. Channel Strategies
21.2.9. Gestalt Diagnostics
21.2.9.1. Overview
21.2.9.2. Product & Services Portfolio
21.2.9.3. Key Financials
21.2.9.4. Sales Footprint
21.2.9.5. SWOT Analysis
21.2.9.6. Strategy Overview
21.2.9.6.1. Marketing Strategies
21.2.9.6.2. Product & Services Strategies
21.2.9.6.3. Channel Strategies
21.2.10. Carl Zeiss AG
21.2.10.1. Overview
21.2.10.2. Product & Services Portfolio
21.2.10.3. Key Financials
21.2.10.4. Sales Footprint
21.2.10.5. SWOT Analysis
21.2.10.6. Strategy Overview
21.2.10.6.1. Marketing Strategies
21.2.10.6.2. Product & Services Strategies
21.2.10.6.3. Channel Strategies
21.2.11. Olympus Corporation
21.2.11.1. Overview
21.2.11.2. Product & Services Portfolio
21.2.11.3. Key Financials
21.2.11.4. Sales Footprint
21.2.11.5. SWOT Analysis
21.2.11.6. Strategy Overview
21.2.11.6.1. Marketing Strategies
21.2.11.6.2. Product & Services Strategies
21.2.11.6.3. Channel Strategies
21.2.12. Abbott Laboratories, Inc
21.2.12.1. Overview
21.2.12.2. Product & Services Portfolio
21.2.12.3. Key Financials
21.2.12.4. Sales Footprint
21.2.12.5. SWOT Analysis
21.2.12.6. Strategy Overview
21.2.12.6.1. Marketing Strategies
21.2.12.6.2. Product & Services Strategies
21.2.12.6.3. Channel Strategies
21.2.13. NeoGenomics Laboratories
21.2.13.1. Overview
21.2.13.2. Product & Services Portfolio
21.2.13.3. Key Financials
21.2.13.4. Sales Footprint
21.2.13.5. SWOT Analysis
21.2.13.6. Strategy Overview
21.2.13.6.1. Marketing Strategies
21.2.13.6.2. Product & Services Strategies
21.2.13.6.3. Channel Strategies
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
Cellular Pathology Market
